novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
Published 1 year ago • 90 plays • Length 0:47Download video MP4
Download video MP3
Similar videos
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
3:31
phe885, a novel bcma-directed car-t therapy for patients with r/r multiple myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
0:49
novel targets for car-t therapy in mcl
-
2:29
myeloma highlights at ash 2022: bites, car-t therapy, novel targets, and more
-
14:10
highlights in multiple myeloma: improving access to car-t therapy, novel targets & future outlooks
-
1:55
updates in immunotherapy for multiple myeloma: bites & novel targets
-
4:58
novel immunotherapies transforming r/r myeloma treatment: bispecifics, car-t cells & more
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:46
allo-715: novel allogenic car t-cell therapy in myeloma
-
2:20
novel car-t products in the pipeline for multiple myeloma
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
5:26
novel immunotherapies for myeloma treatment
-
5:56
advances in car-t therapy for r/r multiple myeloma: ide-cel & cilta-cel
-
2:12
multiple myeloma: elranatamab as a single-agent therapy compared to car-t therapy
-
0:57
novel therapeutic strategies in all
-
1:15
the current status and future of car-t therapy in r/r myeloma
-
1:10
combinatorial car-t approaches being explored in multiple myeloma
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks